Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500).

MLA

Black, W.Cameron, et al. “Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500).” Journal of Medicinal Chemistry, vol. 678, no. 4, Feb. 2024, pp. 2349–68. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.3c01917.

APA

Black, W. C., Abdoli, A., An, X., Auger, A., Beaulieu, P., Bernatchez, M., Caron, C., Chefson, A., Crane, S., Diallo, M., Dorich, S., Fader, L. D., Ferraro, G. B., Fournier, S., Gao, Q., Ginzburg, Y., Hamel, M., Han, Y., Jones, P., & Lanoix, S. (2024). Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500). Journal of Medicinal Chemistry, 678(4), 2349–2368. https://doi.org/10.1021/acs.jmedchem.3c01917

Chicago

Black, W. Cameron, Abbas Abdoli, Xiuli An, Anick Auger, Patrick Beaulieu, Michel Bernatchez, Cathy Caron, et al. 2024. “Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500).” Journal of Medicinal Chemistry 678 (4): 2349–68. doi:10.1021/acs.jmedchem.3c01917.